CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464097528
- Phone
- 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,092
- in 3 filings, $19K under 10b5-1 plans
Net −$19,092. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-13 | Hopfield Jessica Director | Purchase | +45,000 | $5.64 | $254K | 67,700 |
| 2021-03-03 | Hopfield Jessica Director | Purchase | +5,800 | $45.51 | $264K | 22,700 |
| 2021-03-02 | MULLEN JAMES C CEO | Purchase | +25,000 | $46.27 | $1.2M | 35,000 |
| 2019-03-05 | Hopfield Jessica Director | Purchase | +10,200 | $23.94 | $244K | 16,900 |
Page 1 of 1 · 4 trades